Finasteride and male breast cancer: Does the MHRA report show a link?
Finasteride is an important drug for the management of androgenetic alopecia. However, there are concerns about the possible side effects of the drug such as impotence. Recently stray reports have appeared about the occurrence of male breast carcinoma in patients who received the drug. These have be...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2010-01-01
|
Series: | Journal of Cutaneous and Aesthetic Surgery |
Subjects: | |
Online Access: | http://www.jcasonline.com/article.asp?issn=0974-2077;year=2010;volume=3;issue=2;spage=102;epage=105;aulast=Shenoy |
id |
doaj-0cd6a3b2575f4eeaa6f67ce47ebb9d88 |
---|---|
record_format |
Article |
spelling |
doaj-0cd6a3b2575f4eeaa6f67ce47ebb9d882020-11-25T00:04:22ZengWolters Kluwer Medknow PublicationsJournal of Cutaneous and Aesthetic Surgery 0974-20772010-01-013210210510.4103/0974-2077.69022Finasteride and male breast cancer: Does the MHRA report show a link?Niraj K ShenoySangolli M PrabhakarFinasteride is an important drug for the management of androgenetic alopecia. However, there are concerns about the possible side effects of the drug such as impotence. Recently stray reports have appeared about the occurrence of male breast carcinoma in patients who received the drug. These have been looked in to by Medicines and Health care products Regulatory Agency (MHRA). This article summarizes the MHRA report.http://www.jcasonline.com/article.asp?issn=0974-2077;year=2010;volume=3;issue=2;spage=102;epage=105;aulast=ShenoyFinasteridebreast cancermale |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Niraj K Shenoy Sangolli M Prabhakar |
spellingShingle |
Niraj K Shenoy Sangolli M Prabhakar Finasteride and male breast cancer: Does the MHRA report show a link? Journal of Cutaneous and Aesthetic Surgery Finasteride breast cancer male |
author_facet |
Niraj K Shenoy Sangolli M Prabhakar |
author_sort |
Niraj K Shenoy |
title |
Finasteride and male breast cancer: Does the MHRA report show a link? |
title_short |
Finasteride and male breast cancer: Does the MHRA report show a link? |
title_full |
Finasteride and male breast cancer: Does the MHRA report show a link? |
title_fullStr |
Finasteride and male breast cancer: Does the MHRA report show a link? |
title_full_unstemmed |
Finasteride and male breast cancer: Does the MHRA report show a link? |
title_sort |
finasteride and male breast cancer: does the mhra report show a link? |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of Cutaneous and Aesthetic Surgery |
issn |
0974-2077 |
publishDate |
2010-01-01 |
description |
Finasteride is an important drug for the management of androgenetic alopecia. However, there are concerns about the possible side effects of the drug such as impotence. Recently stray reports have appeared about the occurrence of male breast carcinoma in patients who received the drug. These have been looked in to by Medicines and Health care products Regulatory Agency (MHRA). This article summarizes the MHRA report. |
topic |
Finasteride breast cancer male |
url |
http://www.jcasonline.com/article.asp?issn=0974-2077;year=2010;volume=3;issue=2;spage=102;epage=105;aulast=Shenoy |
work_keys_str_mv |
AT nirajkshenoy finasterideandmalebreastcancerdoesthemhrareportshowalink AT sangollimprabhakar finasterideandmalebreastcancerdoesthemhrareportshowalink |
_version_ |
1725429844846575616 |